Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
22M
-
Number of holders
-
33
-
Total 13F shares, excl. options
-
6.39M
-
Shares change
-
+119K
-
Total reported value, excl. options
-
$19.8M
-
Value change
-
+$369K
-
Put/Call ratio
-
0.09
-
Number of buys
-
12
-
Number of sells
-
-8
-
Price
-
$3.09
Significant Holders of EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) as of Q3 2024
36 filings reported holding XGN - EXAGEN INC. - Common Stock, par value $0.001 per share as of Q3 2024.
EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) has 33 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.39M shares
of 22M outstanding shares and own 29.01% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (1.51M shares), COWEN AND COMPANY, LLC (891K shares), SILVERCREST ASSET MANAGEMENT GROUP LLC (541K shares), Stonepine Capital Management, LLC (534K shares), VANGUARD GROUP INC (491K shares), WASATCH ADVISORS LP (490K shares), MORGAN STANLEY (482K shares), PERKINS CAPITAL MANAGEMENT INC (459K shares), RENAISSANCE TECHNOLOGIES LLC (176K shares), and KENNEDY CAPITAL MANAGEMENT LLC (170K shares).
This table shows the top 33 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.